Date: Apr 27, 2011 Source: (
click here to go to the source)
Malaria research to be combined with a systems biology approach
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity. Ruobing Wang, M.D., Ph.D., will lead the study -- Seattle BioMed's first to include the integration of its recently announced systems biology approach to infectious disease research -- with a team that includes Seattle BioMed's Stefan Kappe, Ph.D., and Alan Aderem, Ph.D., along with Patrick Duffy, M.D., of the National Institutes of Health, Jonathan Derry, Ph.D., of Sage Bionetworks, and Xiaowu Liang, Ph.D., of Antigen Discovery Inc. (ADi).
